GlassScriptPhysician profile
Paul M Kidder
NPI 1730395179
$2,670.09
in general payments reported to CMS, 2019-2025
14 companies · $75.74 in 2025
The $75.74 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,517 · 2020: $49.66 · 2021: $114 · 2022: $509 · 2023: $353 · 2024: $51.31 · 2025: $75.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,137.04 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $206.47 | 2022-2024 | Ligasure, Truclear |
| Hologic Sales and Service, LLC | $101.64 | 2022-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Astellas Pharma US INC | $57.42 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $23.45 | 2023 | |
| Baxter Healthcare | $23.20 | 2023 | Tisseel |
| Organon LLC | $18.49 | 2023 | Nexplanon |
| Therapeuticsmd, INC. | $17.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.78 | 2024 | |
| Lsi Solutions INC | $16.20 | 2023 | Fornisee |
| Shield Therapeutics INC | $15.23 | 2023 | Accrufer |
| Minerva Surgical, INC | $13.31 | 2023 | |
| Pfizer INC. | $12.04 | 2022 | |
| Ethicon US, LLC | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kidder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.